Rivastigmine_tartrate: profile and news






UPDATE 1-Novartis drug works for Parkinson's-FDA staffer  16 May 2006
Exelon, known generically as rivastigmine tartrate, was approved in 2000 to improve memory and thinking in Alzheimer's patients. ... - Reuters

Peripheral and Central Nervous System Drugs Advisory Committee  May 12, 2006
The committee will discuss supplemental new drug application (NDA) 20823, SE1-016, EXELON (rivastigmine tartrate) Capsules (1.5 milligrams (mg), 3.0 mg, 4.5 mg ... - FDA.gov


Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org